WebOct 18, 2024 · October 18, 2024—Inari Medical, Inc. announced planned enrollment of the PEERLESS randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the company’s FlowTriever system versus catheter-directed thrombolysis (CDT). WebFeb 26, 2016 · FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. …
A novel technique for the percutaneous removal of tricuspid valve ...
WebDec 17, 2024 · The INARI FlowTriever Catheter; has 3 expanding nitinol mesh disks; available in 4 sizes: Small (6–10 mm), Medium (11–12 mm), (large 15–18 mm), and X large (19–25 mm), designed to engage and disrupt venous clots and subsequently deliver it to the large bore aspiration catheter. WebOct 18, 2024 · IRVINE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of... cthbfk ytn
Inari Medical Announces Three New Data Sets to be Presented
WebMay 13, 2024 · Objectives: The aim of this study was to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the FlowTriever System … WebAug 30, 2024 · August 30, 2024—Inari Medical, Inc. announced the planned enrollment of the DEFIANCE randomized controlled trial (RCT). The trial will compare clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the company’s ClotTriever system versus treatment with anticoagulation only. WebMar 6, 2024 · FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System By: Inari Medical, Inc. via Globe NewsWire March 06, 2024 at 08:00 AM EST earth hackney whats on